Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X.

Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease-Related Decline

Cullen N, Janelidze S, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

Neurology. 2022 Mar 1;98(9):e958-e967. doi: 10.1212/WNL.0000000000013228. Epub 2021 Dec 22.

Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease: The Need for a Holistic View of the Early Pathogenesis

Merlo S, Spampinato SF, Lim D.

Biomolecules. 2021 Dec 1;11(12):1807. doi: 10.3390/biom11121807.

A case report of late-onset schizophrenia differentiated from a dementing disorder

Shimada T, Uehara T, Nagasawa T, Hasegawa M, Maeda Y, Kawasaki Y.

Neurocase. 2021 Dec;27(6):467-473. doi: 10.1080/13554794.2021.2016858. Epub 2021 Dec 23.

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease

Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, Luca IS, Ciobica A, Kazis D.

Medicina (Kaunas). 2021 Dec 30;58(1):60. doi: 10.3390/medicina58010060.

The Impact of Systemic Inflammation on Alzheimer's Disease Pathology

Xie J, Van Hoecke L, Vandenbroucke RE.

Front Immunol. 2022 Jan 6;12:796867. doi: 10.3389/fimmu.2021.796867. eCollection 2021.

Diabetes and cognitive decline

Bellia C, Lombardo M, Meloni M, Della-Morte D, Bellia A, Lauro D.

Adv Clin Chem. 2022;108:37-71. doi: 10.1016/bs.acc.2021.07.006. Epub 2021 Aug 23.

Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

Shi Y, Gu L, Wang Q, Gao L, Zhu J, Lu X, Zhou F, Zhu D, Zhang H, Xie C, Zhang Z.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):664-670. doi: 10.1093/gerona/glz005.

The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):47-53. doi: 10.1097/WAD.0000000000000342.

Update on posterior cortical atrophy

Holden SK, Bettcher BM, Pelak VS.

Curr Opin Neurol. 2020 Feb;33(1):68-73. doi: 10.1097/WCO.0000000000000767.

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial

Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.

JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.

Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease

Cantero JL, Atienza M, Lage C, Zaborszky L, Vilaplana E, Lopez-Garcia S, Pozueta A, Rodriguez-Rodriguez E, Blesa R, Alcolea D, Lleo A, Sanchez-Juan P, Fortea J; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224.

Current opinion neurology: visual pathway biomarkers in Alzheimer's disease

Van Stavern GP.

Curr Opin Neurol. 2020 Feb;33(1):79-86. doi: 10.1097/WCO.0000000000000788.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias